Hydroxychloroquine may have a treatment role for chronic inflammatory cardiomyopathy

1. Hydroxychloroquine plus prednisolone reduced the 12-month risk of the composite cardiovascular outcome by 72 percent compared with prednisolone alone. 2. Hydroxychloroquine plus prednisolone normalized a wide range of inflammation-related proteins, indicating multiple anti-inflammatory effects. 3. The safety profile was similar to prednisolone alone, with no serious treatment-related adverse events. Evidence Rating Level: 1 (Excellent) […]